Watch ISPC. Know when insiders buy.
One email the day a filing lands. Free.
ISPC
iSpecimen Inc.
0.90
−0.06 −6.24%
USD · close Oct 21
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
60
WATCH · shorts 60
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $2.3MP/E —DIV YIELD —FCF YIELD —REV TTM $466K −92.1%NET INCOME −$11.4MNET CASH $983K52W 0.90 – 34.40SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $152K | −78.7% | 45.2% | −$1.4M | −$1.4M | — | -0.98 | −$690K | — | — | Aug 14 |
| Q1 2026 · Mar 31 | $156K | −85.2% | 45.9% | −$2.5M | −$2.3M | — | -6.66 | −$3.4M | — | — | Aug 14 |
| Q4 2025 · Dec 31derived | $52K | −96.5% | -964.4% | −$2.7M | −$5M | — | -0.74 | −$917K | $0 | −$917K | Apr 1 |
| Q3 2025 · Sep 30 | $107K | −96.0% | -91.9% | −$2.8M | −$2.8M | — | -0.48 | −$2M | $0 | −$2M | Nov 17 |
| Q2 2025 · Jun 30 | $713K | −75.1% | 37.7% | −$1.8M | −$1M | — | -16.78 | −$192K | — | — | Aug 14 |
| Q1 2025 · Mar 31 | $1.1M | −53.8% | 42.4% | −$1.6M | −$1.7M | — | -28.55 | −$1.1M | — | — | Aug 14 |
| Q4 2024 · Dec 31derived | $1.5M | −42.7% | 13.5% | −$5.8M | −$6M | — | -6.28 | −$3.6M | $8K | −$3.6M | Apr 1 |
| Q3 2024 · Sep 30 | $2.7M | −4.2% | 41.6% | −$1.7M | −$1.4M | — | -2.10 | −$1.1M | $15K | −$1.1M | Nov 17 |
| Q2 2024 · Jun 30 | $2.9M | — | 50.3% | −$2.2M | −$2.1M | — | -3.72 | −$1.5M | $0 | −$1.5M | Nov 17 |
| Q1 2024 · Mar 31 | $2.3M | — | 58.4% | −$3M | −$2.9M | — | -6.36 | −$2.1M | $9K | −$2.1M | Nov 17 |
| Q4 2023 · Dec 31derived | $2.6M | — | 46.5% | −$2.9M | −$3.1M | — | -6.77 | $345K | $0 | $345K | Apr 14 |
| Q3 2023 · Sep 30 | $2.8M | — | 49.9% | −$2.2M | −$2.1M | — | -4.66 | −$1.6M | $6K | −$1.6M | Nov 7 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $1.9M | 11.2% | −$9M | −$10.5M | -543.7% | -2.28 | −$4.2M | $454 | −$4.2M | — | — |
| FY2024 · to Dec 31 | $9.3M | 45.0% | −$12.7M | −$12.5M | -134.5% | -17.58 | −$8.3M | $32K | −$8.3M | — | — |
| FY2023 · to Dec 31 | $9.9M | 51.9% | −$11.2M | −$11.1M | -111.8% | -24.55 | −$5.8M | $19K | −$5.8M | — | — |
| FY2022 · to Dec 31 | $10.4M | 54.3% | −$10.2M | −$10.2M | -98.5% | -1.16 | −$5.8M | $216K | −$6M | — | — |
| FY2021 · to Dec 31 | $11.1M | 52.9% | −$5.9M | −$9M | -80.5% | -2.09 | −$10.7M | $3K | −$10.7M | — | — |
| FY2020 · to Dec 31 | $8.2M | 56.2% | −$2.4M | −$4.7M | -56.8% | -4.97 | −$288K | $426 | −$289K | — | — |
Every number comes from iSpecimen Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.